Code Bio
Founded in August 2019, Dianma Bio was founded by Dr. Ma Donghui, a former general manager of OriGene, a benchmarking enterprise in the industry, a PhD from the National University of Singapore, and a postdoctoral fellow from Hopkins University. The company is committed to the development and production of monoclonal antibodies against tumor immune targets, providing multi-faceted solutions for scientific research, clinical diagnosis and drug development worldwide. The company has an original digital monoclonal antibody technology that greatly improves the efficiency of research and development, and cuts into the high-demand market of imported imported pathological antibodies. Currently, it has completed the development of multiple series of products.
Suzhou Dianma Biological Technology Co., Ltd.
contact details
address:
Suzhou-Room 511-2, Building 2, No. 8, Jinfeng Road, High-tech Zone, Suzhou
Wuhan-Room D101, Building B7, Optics Valley Biological City, No. 666 Gaoxin Avenue, East Lake High-tech Zone, Wuhan
Phone: 027-87002742
Official website:：www.recmab.com
WeChat public account:
